Early toxicity in a randomized trial of high dose-rate (HDR) brachytherapy as monotherapy for low- and intermediate-risk prostate cancer

This publication has no relations, dolmen is empty

Category Primary study
JournalJournal of Clinical Oncology
Year 2016
This article has no abstract
Epistemonikos ID: 0fb5f079e9560251fe0185668db92ce8310d98d8
First added on: Feb 07, 2025